IL17A and rheumatoid arthritis: Furthermore, models using IL-17-deficient mice or in which IL-17 was blocked by antibody treatment showed reduced inflammation and disease severity in rheumatoid arthritis and experimental autoimmune encephalomyelitis (EAE) models, further linking IL-23, IL-17 and autoimmune disease [14,16,54,55,56].